Center-Authored Papers

Filters: Author is Young, Joanne P  [Clear All Filters]
2016
Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H et al..  2016.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.. International journal of cancer. 139(7):1557-1563. Abstract
Chau R, Dashti SG, Ouakrim DA, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA et al..  2016.  Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.. International journal of epidemiology. 45(3):940-953. Abstract
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S et al..  2016.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort.. BMJ open. 6(2):e010293. Abstract
2015
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW et al..  2015.  Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.. JAMA. 314(1):61-71. Abstract
Antill YC, Dowty JG, Win AK, Thompson T, Walsh MD, Cummings MC, Gallinger S, Lindor NM, Le Marchand L, Hopper JL et al..  2015.  Lynch Syndrome and Cervical Cancer.. International journal of cancer. Journal international du cancer. 137(11):2757-61. Abstract
Win AK, Reece JC, Buchanan DD, Clendenning M, Young JP, Cleary SP, Kim H, Cotterchio M, Dowty JG, MacInnis RJ et al..  2015.  Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.. Familial cancer. 14(4):575-83. Abstract
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M et al..  2015.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.. Gut. 64(1):101-10. Abstract
2014
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG et al..  2014.  Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, with and without a Family History of Cancer.. Gastroenterology. Abstract
2013
Win AK, Hopper JL, Buchanan DD, Young JP, Tenesa A, Dowty JG, Giles GG, Goldblatt J, Winship I, Boussioutas A et al..  2013.  Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? European journal of cancer (Oxford, England : 1990). 49(7):1578-87. Abstract
Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler BN, Pearson S-A, Macrae F, Parry S, Arnold J et al..  2013.  Family History of Colorectal Cancer in BRAF p.V600E mutated Colorectal Cancer Cases.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S et al..  2013.  Cancer Risks for MLH1 and MSH2 Mutation Carriers.. Human mutation. 34(3):490-7. Abstract
Win AK, Parry S, Parry B, Kalady MF, Macrae FA, Ahnen DJ, Young GP, Lipton L, Winship I, Boussioutas A et al..  2013.  Risk of Metachronous Colon Cancer Following Surgery for Rectal Cancer in Mismatch Repair Gene Mutation Carriers.. Annals of surgical oncology. 20(6):1829-1836. Abstract
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J et al..  2013.  Risks of colorectal and other cancers after endometrial cancer for women with lynch syndrome.. Journal of the National Cancer Institute. 105(4):274-9. Abstract
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, Le Marchand L, Haile R, Gallinger S et al..  2013.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial cancer. 12(3):563-6. Abstract
2012
Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, Parsons MT, Michael D, Gallinger S, Haile RW et al..  2012.  A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry.. Human mutation. Abstract
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I et al..  2012.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(9):958-64. Abstract
Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband BH et al..  2012.  Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22.. PloS one. 7(5):e38175. Abstract
2011
Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD et al..  2011.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).. Familial cancer. 10(2):245-54. Abstract
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I et al..  2011.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.. Gut. 60(7):950-7. Abstract
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L et al..  2011.  Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.. Obstetrics and gynecology. 117(4):899-905. Abstract
2010
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC et al..  2010.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.. International journal of cancer. Journal international du cancer. Abstract
Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb PA, Parry S, Hopper JL, Haile R, Jenkins MA.  2010.  Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.. International journal of cancer. Journal international du cancer. 127(11):2678-84. Abstract